Description

In this episode, the panellists evaluate past efforts, current trials, and the evolving landscape of HBV cure research. They also weigh the patient-friendliness of these strategies, exploring potential pathways to a cure. How will the landscape of trials and research methodologies evolve in the future to facilitate this quest?

Faculty

  • Ahmed Elsharkawy (Moderator)
  • Markus Cornberg (Faculty)
  • Dickens Theodore (GSK Representative)
  • Su Wang (Faculty)

This EASL Studio is supported by GSK.

Related episodes:

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

Log in to post comments